Lazard Capital Downgrades ABIOMED (ABMD) to Neutral
Tweet Send to a FriendGet Alerts ABMD Hot Sheet
Price: $21.72 -0.5%
Rating Summary:
6 Buy, 2 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
6 Buy, 2 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade ABMD Now!
Lazard Capital downgraded ABIOMED (NASDAQ: ABMD) from Buy to Neutral.
For an analyst ratings summary and ratings history on ABIOMED click here. For more ratings news on ABIOMED click here.
Shares of ABIOMED closed at $24.29 yesterday, with a 52 week range of $9.98-$26.17.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on ABIOMED click here. For more ratings news on ABIOMED click here.
Shares of ABIOMED closed at $24.29 yesterday, with a 52 week range of $9.98-$26.17.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: JPMorgan Cuts SodaStream (SODA) to Neutral, 'Stock No Longer Cheap'
- Standpoint Research Downgrades Delta Air Lines (DAL) to Hold
- Standpoint Research Downgrades Guess (GES) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Lazard
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
